These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 17690553

  • 41. [Two cases of Creutzfeldt-Jakob disease with high neuron-specific enolase level in cerebrospinal fluid].
    Jimi T, Wakayama Y, Shibuya S, Hara H, Sagawa F, Hashizume Y.
    Rinsho Shinkeigaku; 1989 Jan; 29(1):118-21. PubMed ID: 2663293
    [Abstract] [Full Text] [Related]

  • 42. Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease.
    Steinacker P, Rist W, Swiatek-de-Lange M, Lehnert S, Jesse S, Pabst A, Tumani H, von Arnim CA, Mitrova E, Kretzschmar HA, Lenter M, Wiltfang J, Otto M.
    Proteomics; 2010 Jan; 10(1):81-9. PubMed ID: 19882659
    [Abstract] [Full Text] [Related]

  • 43. [Creutzfeldt-Jakob disease: alterations in an isolated cortical signal in diffusion magnetic resonance imaging].
    Moreno-Izco F, Martínez-Gil A.
    Rev Neurol; 2010 Jan; 40(1):38-42. PubMed ID: 15696425
    [Abstract] [Full Text] [Related]

  • 44. Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry.
    Skillbäck T, Rosén C, Asztely F, Mattsson N, Blennow K, Zetterberg H.
    JAMA Neurol; 2014 Apr; 71(4):476-83. PubMed ID: 24566866
    [Abstract] [Full Text] [Related]

  • 45. Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants.
    Appleby BS, Appleby KK, Crain BJ, Onyike CU, Wallin MT, Rabins PV.
    Arch Neurol; 2009 Feb; 66(2):208-15. PubMed ID: 19204157
    [Abstract] [Full Text] [Related]

  • 46. [New investigations in suspected Creutzfeldt-Jakob disease. Analysis of 14-3-3 protein and T-tau in cerebrospinal fluid for safer diagnosis].
    Zetterberg H, Hammarin AL, Nilsson P, Andersson E, Lind B, Blennow K.
    Lakartidningen; 2009 Feb; 102(12-13):956-8, 960-1. PubMed ID: 15887642
    [Abstract] [Full Text] [Related]

  • 47. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
    Koscova S, Zakova Slivarichova D, Tomeckova I, Melicherova K, Stelzer M, Janakova A, Kosorinova D, Belay G, Mitrova E.
    Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
    [Abstract] [Full Text] [Related]

  • 48. [Cerebrospinal fluid markers of prion diseases].
    Golańska E, Gresner S, Sieruta M, Liberski P.
    Neurol Neurochir Pol; 2008 Oct; 42(5):441-50. PubMed ID: 19105113
    [Abstract] [Full Text] [Related]

  • 49. [Creutzfeldt-Jakob disease: diagnostic value of protein 14-3-3 and neuronal specific enolase assay in cerebrospinal fluid].
    Brandel JP, Beaudry P, Delasnerie-Lauprêtre N, Laplanche JL.
    Rev Neurol (Paris); 1999 Feb; 155(2):148-51. PubMed ID: 10226319
    [Abstract] [Full Text] [Related]

  • 50. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.
    Coulthart MB, Jansen GH, Olsen E, Godal DL, Connolly T, Choi BC, Wang Z, Cashman NR.
    BMC Neurol; 2011 Oct 27; 11():133. PubMed ID: 22032272
    [Abstract] [Full Text] [Related]

  • 51. ERK2 is increased in cerebrospinal fluid of Creutzfeldt-Jakob disease patients.
    Steinacker P, Klafki H, Lehnert S, Jesse S, Arnim CA, Tumani H, Pabst A, Kretzschmar HA, Wiltfang J, Otto M.
    J Alzheimers Dis; 2010 Oct 27; 22(1):119-28. PubMed ID: 20847405
    [Abstract] [Full Text] [Related]

  • 52. CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias.
    Holsinger RM, Lee JS, Boyd A, Masters CL, Collins SJ.
    Neurology; 2006 Aug 22; 67(4):710-2. PubMed ID: 16924032
    [Abstract] [Full Text] [Related]

  • 53. [Correlation of diffusion-weighted magnetic resonance imaging with neurological deficits in sporadic Creutzfeldt-Jakob Disease].
    Eschweiler GW, Wormstall H, Widmann U, Naegele T, Bartels M.
    Nervenarzt; 2002 Sep 22; 73(9):883-6. PubMed ID: 12215882
    [Abstract] [Full Text] [Related]

  • 54. Diffusion-weighted MRI in familial Creutzfeldt-Jakob disease with the codon 200 mutation in the prion protein gene.
    Tsuboi Y, Baba Y, Doh-ura K, Imamura A, Fujioka S, Yamada T.
    J Neurol Sci; 2005 May 15; 232(1-2):45-9. PubMed ID: 15850581
    [Abstract] [Full Text] [Related]

  • 55. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement.
    Tschampa HJ, Kallenberg K, Urbach H, Meissner B, Nicolay C, Kretzschmar HA, Knauth M, Zerr I.
    Brain; 2005 Sep 15; 128(Pt 9):2026-33. PubMed ID: 15958503
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. The axonal damage marker tau protein in the cerebrospinal fluid is increased in patients with acute encephalopathy with biphasic seizures and late reduced diffusion.
    Tanuma N, Miyata R, Kumada S, Kubota M, Takanashi J, Okumura A, Hamano S, Hayashi M.
    Brain Dev; 2010 Jun 15; 32(6):435-9. PubMed ID: 19679415
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Clinical algorithm for cerebrospinal fluid test of 14-3-3 protein in diagnosis of Creutzfeldt-Jacob disease].
    Lemstra AW, van Meegen M, Baas F, van Gool WA.
    Ned Tijdschr Geneeskd; 2001 Jul 28; 145(30):1467-71. PubMed ID: 11503317
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.